Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to -$2.9 million.

  • Marimed's Consolidated Net Income fell 19707.07% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 2541.25%. This contributed to the annual value of -$12.2 million for FY2024, which is 2398.33% up from last year.
  • Marimed's Consolidated Net Income amounted to -$2.9 million in Q3 2025, which was down 19707.07% from -$1.3 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Consolidated Net Income ranged from a high of $7.6 million in Q2 2021 and a low of -$10.1 million during Q4 2023
  • In the last 5 years, Marimed's Consolidated Net Income had a median value of -$990000.0 in 2024 and averaged -$859842.1.
  • As far as peak fluctuations go, Marimed's Consolidated Net Income soared by 76498.31% in 2021, and later tumbled by 31950.46% in 2025.
  • Over the past 5 years, Marimed's Consolidated Net Income (Quarter) stood at -$6.4 million in 2021, then surged by 174.13% to $4.7 million in 2022, then crashed by 313.5% to -$10.1 million in 2023, then rose by 21.08% to -$8.0 million in 2024, then skyrocketed by 63.25% to -$2.9 million in 2025.
  • Its Consolidated Net Income stands at -$2.9 million for Q3 2025, versus -$1.3 million for Q2 2025 and -$5.4 million for Q1 2025.